Evidence map›Paper›PMID 23805324›Full record

ArticlePloS one2013

Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.

Amanda Jacobson, Frank Bell, Nicholas Lejarcegui, Caroline Mitchell, Lisa Frenkel, Helen Horton

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. CD56 on immune and tumor cells: what is known and beyond?Clinical and experimental immunology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Is Infant Immunity Actively Suppressed or Immature?Virology : research and treatment · 2014
    Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Amanda JacobsonSeattle Biomedical Research Institute, Seattle, Washington, United States of America.
Frank Bell
Nicholas Lejarcegui
Caroline Mitchell
Lisa Frenkel
Helen Horton
Center for Infectious Disease Research · USSeattle Children's Hospital · USUniversity of Washington · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Myeloid-derived Suppressor cells (MDSC) suppress infant immune responsesR01AI100018 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI URDAHL, KEVIN B · 2012 to 2016
$2.2M
NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI100018
6 · The paper itself

Abstract

backgroundNeonatal Natural Killer (NK) cells show functional impairment and expansion of a CD56 negative population of uncertain significance.

methodsNK cells were isolated from cord blood and from adult donors. NK subpopulations were identified as positive or negative for the expression of CD56 and characterized for expression of granzyme B and surface markers by multi-parameter flow cytometry. Cell function was assessed by viral suppression and cytokine production using autologous lymphocytes infected with HIV. Activating (NKp30, NKp46) and inhibitory (Siglec-7) markers in healthy infants and adults were compared with viremic HIV-infected adults.

resultsCord blood contained increased frequencies of CD56 negative (CD56neg) NK cells with reduced expression of granzyme B and reduced production of IFNγ and the CC-class chemokines RANTES, MIP1α and MIP1β upon stimulation. Both CD56pos and CD56neg NK subpopulations showed impaired viral suppression in cord blood, with impairment most marked in the CD56neg subset. CD56neg NK cells from cord blood and HIV-infected adults shared decreased inhibitory and activating receptor expression when compared with CD56pos cells.

conclusionsCD56neg NK cells are increased in number in normal infants and these effectors show reduced anti-viral activity. Like the expanded CD56neg population described in HIV-infected adults, these NK cells demonstrate functional impairments which may reflect inadequate development or activation.

Indexed as

AdultAntigens, Differentiation, MyelomonocyticCD4-Positive T-LymphocytesCD56 AntigenChemokinesCytokinesFetal BloodGranzymesHIVHIV InfectionsHumansImmunoassayInterferon-gammaKiller Cells, NaturalLectinsNatural Cytotoxicity Triggering Receptor 1Antigens, Differentiation, MyelomonocyticCD56 AntigenChemokinesCytokinesGranzymesInterferon-gammaLectinsNatural Cytotoxicity Triggering Receptor 1Natural Cytotoxicity Triggering Receptor 3NCR1 protein, humanNCR3 protein, humanSIGLEC7 protein, human

Identifiers

PMID23805324
PMCPMC3689709
OpenAlexW1975768197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.